跳至主要内容
临床试验/ITMCTR2200006040
ITMCTR2200006040招募中未知

the therapeutic effect of Shiwei Qingyang Decoction on Omicron variant of COVID-19 infection

Shuguang Hospital affiliated with Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Treatment study

入排标准

年龄范围
18 至 75(—)
性别
All

入选标准

  • 1. Coronavirus infection (nucleic acid tests or antigen test was positive, CT value <40), mild or asymptomatic coronavirus carriers;
  • 2. Entered the fangcang hospital which was taken over by Shuguang Hospital affiliated with Shanghai University of Traditional Chinese Medicine;
  • 3. who have given informed consent and accept the treatment of Shiwei Qingyang Decoction;
  • 4. aged from 18 to 75 years
  • Note: only those who meet the above 4 criteria can be included in this study.

排除标准

  • 1. unwilling to accept the treatment of Shiwei Qingyang Decoction;
  • 2, unconsciousness, failure to express subjective discomfort symptoms and mental disorder patients;
  • 3, accompanied by more than one severe secondary progressive malignancy or other severe wasting diseases;
  • 4. Patients with severe symptoms of depression and anxiety;
  • 5. Age <18 or age >75
  • Note: patients who met any of the above criteria were excluded.

研究者

发起方
Shuguang Hospital affiliated with Shanghai University of Traditional Chinese Medicine

相似试验